Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities - Accrued Liabilities (Details)

v3.24.2.u1
Note 8 - Accrued Liabilities - Accrued Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Clinical trial costs $ 903 $ 258
Research and development services 688 632
Compensation 473 766
Professional services fees 155 98
Other 10 23
Total accrued liabilities $ 2,229 $ 1,777